Atlas Trials

Phase 2 Study Of Neoadjuvant Iressa Treatment In Stage 1 NSCLC

Clinical trial NCT00188617 · COMPLETED

Trial details

NCT number
NCT00188617
Sponsor
University Health Network, Toronto
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
LUNG CANCER
Start date
2005-01-01
Primary completion
2007-06-01
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.